For millions worldwide, herpes zoster pain does not end when the rash fades. Postherpetic neuralgia can last for years or ...
In most patients with idiopathic inflammatory myopathies, recombinant zoster vaccine induces seroconversion, but the antibody levels remain low compared with those in healthy individuals.
Shingles, a condition triggered by the reactivation of the varicella-zoster virus in the body, can cause a “war zone” of ...
Learn the correct pronunciation of the Zoster Vaccine Live, understand it's uses, recommended dosages, its indications, how to take, when to take, when not to take, side effects, special precautions, ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
Uptake of the recombinant zoster vaccine (RZV) among adults with rheumatic diseases in the 20 months following the updated 2021 recommendations ranged from 7% to just more than 10% across conditions.
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Herpes zoster vaccination is effective in patients with systemic lupus erythematosus and multiple ...
A new global systematic literature review and meta-analysis has shown that herpes zoster vaccination, used to prevent shingles, is associated with a statistically significant lower risk of heart ...
Older adults that receive the herpes zoster vaccine in the first 12 months following admission to care facilities have a reduced risk for dementia.
In previous phase 1–2 clinical trials involving older adults, a subunit vaccine containing varicella–zoster virus glycoprotein E and the AS01 B adjuvant system (called HZ/su) had a clinically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results